GarethJMorganMD

PubMed

• 82 citations
  Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma
  Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper
  Blood Advances. 2021-04-27
• 1065 citations
  The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
  Boyd Swinburn, Vivica I. Kraak, Steven Allender, Vincent J Atkins, Phillip Baker
  Lancet. 2019-02-23
• 2422 citations
  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations:...
  J. J. M. Van Dongen, Anthonie Willem Langerak, Monika Brüggemann, Paul Evans, Michael Hummel
  Leukemia. 2003-12-01

Lectures

• Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Characterisation of Long-Term Responders to First-Line Myeloma Therapy – Results from the UK Myeloma IX and XI Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all